Gregory Lemkine

PhD, Founder and chief executive officer of WatchFrog

Dr Lemkine has a thorough understanding of the technical, scientific and marketing of biotechnologies and completed a training/action cycle of HEC school of management. Prior to inception of the company, Dr Lemkine was in charge of technology transfer in the Museum National d'Histoire Naturelle in Paris. He holds a PhD in Physiology and has published many articles in international scientific journals.

Barbara Demeneix

Prof. PhD., Co-founder and chairman of the Scientific Council of WatchFrog

Prof Barbara Demeneix heads the internationally recognized academic laboratory (UMR CNRS 7221/Museum National d'Histoire Naturelle) from which derives WatchFrog's versatile technology (patent exclusively licensed to the company). The main area of expertise of Barbara Demeneix is molecular physiology and endocrinology. Her team is renowned for having developed a number of non-viral somatic gene transfer methods for following transcriptional regulations in vivo and for applying germinal transgenesis with fluorescent proteins in Xenopus. She has a total of 79 original papers, over 20 book chapters and 4 patents. She also has wide management experience and is the coordinator of NoE "CRESCENDO".

Charles Berger

Associate

In charge of Business Development , Charles BERGER is an expert in strategy and marketing and an experienced professional from the pharmaceutical industry and biotechnology.